The global wound care market is on the rise with exorbitant costs incurred each year for skin wound care. Nature-derived drugs with wound healing properties that can be manufactured at a lower cost are presently a global requirement. Now, a study by scientists at Tezpur University has identified the country’s first wound-healing peptide from snake venom with anti-bacterial, anti-inflammatory and non-enzymatic properties.
A team of researchers from the Indian Institute of Science, Bengaluru have come up with a computational model to explain why different people respond differently to viral infections. According to this model, a delicate balance between specific immune cells and viral antigens determines infection outcome.
Uncontrolled blood loss following an accident or injury can pose severe risks to the health and life of the patient. Now, a team of Indian researchers from the Institute of Nano Science and Technology have developed a novel environment-friendly microparticle which can stop bleeding quickly if applied to the injury site.
In a new study, researchers from the University of Delhi have shown how spores of the Anthrax bacteria store information in the form of a “phenotypic memory”. This information ensures that when the conditions are favourable, the spores grow into robust, infectious agents.
Tissue damage is one of the most severe consequences of Type 2 Diabetes and is responsible for most of the advanced complications of this lifestyle disorder. A new study by Indian researchers describes a novel diagnostic protocol to quickly and non-invasively assess tissue damage in diabetics by evaluating the quality of the patients' fingernails.
In a country where more than 80% of medical devices are imported, IIT Bombay researchers have developed India’s first biodegradable bone screw. The screw is made of a polymer-based biomaterial which contains Magnesium Oxide nanoparticles and silk fibres, and its mechanical strength can be tuned to match the target tissue.
Gallbladder cancer has a high rate of incidence in Indian populations and a heavy mortality rate. Now, researchers from ACTREC, Mumbai, have pinpointed a pair of genetic mutations in gallbladder cancer patients, which may serve as potential drug targets for treatment.